Bortezomib for the treatment of multiple myeloma patients

Health Technology Assessment

Volumn 13, Issue SUPPL.1, 2009, Pages 29-34

  Green, C ^a   Bryant, J ^a   Takeda, A ^a   Cooper, K ^a   Clegg, A ^a   Smith, A ^a   Stephens, M ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; PYRAZINE DERIVATIVE;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MULTIPLE MYELOMA; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; COST-BENEFIT ANALYSIS; HUMANS; MULTIPLE MYELOMA; PYRAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 70349263535     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta13suppl1/05     Document Type: Article

References (6)

1. National Institute for Health and Clinical Excellence. Guide to the single technology (STA) process. URL: www.nice.org.uk/page.aspx?o=STAprocessguide. Accessed 19 September 2006.
2. Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004;90:1367-73.
3. Cancer Research UK. Multiple myeloma statistics for he UK. URL: http://info.cancerresearchuk.org/cancerstats/types/multiplemyeloma/?a=5441.
4. Zappasodi P, Corso A, Klersy C, Pica G, Mangiacavalli S, Varettoni M, et al. Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience. Eur J Cancer 2006;42:396-402.
5. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al., editors. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute, Bethesda, MD. URL: http://seer.cancer.gov/csr/1975_2002/. Based on November 2004 SEER data submission, posted to the SEER website 2005.
6. Green C, Bryant J, Takeda A, Cooper K, Clegg A, Smith A, Stephens M. Bortezomib for the treatment of multiple myeloma patients. Evidence review group single technology appraisal for NICE. April 2006.